Interleukin‐10–592C/A, –819C/T and –1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients

I. Ezzidi,N. Mtiraoui,M. Kacem,S. Mallat,M. H. Mohamed,M. Chaieb,T. Mahjoub,W. Almawi
DOI: https://doi.org/10.1111/j.1365-2265.2008.03337.x
2009-03-01
Clinical Endocrinology
Abstract:Background  The Interleukin (IL)‐10 polymorphic variants –1082G/A, –819C/T and –592C/A were linked with obesity, metabolic syndrome, and type 2 diabetes (T2DM). We investigated the hypothesis that IL‐10 promoter polymorphisms may be associated with the progression of diabetic nephropathy (DN).
What problem does this paper attempt to address?